Hans-Juergen Hamann

This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Bayer Animal Health Gmbh, Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Juergen Hamann. Retrieved from https://idiyas.com/inventor/hans-juergen-hamann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 4)

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

2 out of 54

Bayer Animal Health Gmbh

patents

2 out of 721

Bayer Intellectual Property Gmbh

patents

1 out of 387

Bayer Pharma Aktiengesellschaft

Years Active: 2010-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11147764 - Tablets with improved acceptance and good storage stability (2021-10-19),

2. 10543170 - Tablets with improved acceptance and good storage stability (2020-01-28),

3. 10251932 - Preparations containing amorphous emodepside (2019-04-09),

4. 9744127 - Non-starch based soft chewables (2017-08-29),

5. 9095511 - Stabilization of oily suspensions comprising hydrophobic silicas (2015-08-04),

6. 7763583 - Endoparasiticidal compositions for topical application (2010-07-27),

Title: The Innovations of Hans-Juergen Hamann

Introduction

Hans-Juergen Hamann is a notable inventor based in Dormagen, Germany. He has made significant contributions to the field of animal health through his innovative work. With a total of six patents to his name, Hamann has focused on developing solutions that enhance the well-being of animals.

Latest Patents

Among his latest patents are tablets designed for animals, which feature improved acceptance and good storage stability. These tablets are specifically formulated to ensure that animals can easily consume them, thereby promoting better health outcomes. The invention emphasizes the importance of both acceptance and stability in veterinary medicine.

Career Highlights

Hamann has had a distinguished career, working with prominent companies such as Bayer Animal Health GmbH and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to leverage his expertise in developing innovative products for animal care.

Collaborations

Throughout his career, Hamann has collaborated with talented individuals, including Venkata-Rangarao Kanikanti and Georg Schulte. These partnerships have contributed to the advancement of his inventions and the overall success of his projects.

Conclusion

Hans-Juergen Hamann's work in the field of animal health exemplifies the impact of innovation on veterinary medicine. His patents reflect a commitment to improving the quality of life for animals through effective and reliable solutions.

Profile summary based on public USPTO records.